Eli Lilly, Anthem Push Anti-Kickback, Best Price Reforms

Eli Lilly and Company and Anthem released a memo Friday (Jan. 29) asking Congress and the administration to alleviate legislative and regulatory burdens -- including those posed by anti-kickback laws and Medicaid best price policy -- to make it easier for drug makers and health insurers to negotiate value-based payment contracts for drugs. The companies suggest the parameters of such contracts be defined through federal regulation, and say regulators could develop a template memorandum of understanding for payers and manufacturers...